# PTH(1-34) and Pelvic Fracture Healing - a Randomized Controlled Trial

> **NCT02972424** · PHASE2 · COMPLETED · sponsor: **Hospital for Special Surgery, New York** · enrollment: 35 (actual)

## Conditions studied

- Osteoporotic Fractures

## Interventions

- **DRUG:** Teriparatide Prefilled Syringe
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02972424
- **Lead sponsor:** Hospital for Special Surgery, New York
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-01
- **Primary completion:** 2021-03-08
- **Final completion:** 2021-07-08
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2022-07-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02972424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02972424, "PTH(1-34) and Pelvic Fracture Healing - a Randomized Controlled Trial". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02972424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*